Stock listing
Alaunos Therapeutics, Inc.
Selected listing: TCRT · NASDAQ · USD · US
Alaunos Therapeutics, Inc. (NASDAQ:TCRT), Health Technology. Latest release Sep 18, 2026: Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct…
- Ticker
- NASDAQ:TCRT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. (Ticker: TCRT) is a public company based in the United States, focusing on innovative therapies in the field of cancer treatment. Alaunos aims to provide effective solutions for patients through its commitment to therapeutic advancements.
Latest news from Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
September 18, 2026
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
June 29, 2026
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
May 26, 2026
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
May 18, 2026
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
March 2, 2026
Events
Research Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. company profile
View the public company page for Alaunos Therapeutics, Inc. on 6ix.
Alaunos Therapeutics, Inc. news
Read company news and market updates connected to Alaunos Therapeutics, Inc..
Alaunos Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Alaunos Therapeutics, Inc..